Table 3.

Baseline predictors of heart failure-related rehospitalization after discharge

Variable	OR (95% CI)			Wald	P-value
	Early vs. No readmission	Late vs. No readmission	Early vs. Late readmission
History of cerebrovascular disease	0.87 (0.48–1.59)	1.56 (1.10–2.22)	0.56 (0.28–1.10)	6.615	0.037
History of ischaemic heart disease	1.84 (1.14–2.96)	0.83 (0.63–1.10)	2.22 (1.29–3.81)	8.240	0.016
Hospitalization in last year	2.01 (1.30–3.10)	1.85 (1.39–2.46)	1.08 (0.65–1.80)	27.064	<0.001
Latin America vs. North America	0.41 (0.16–1.03)	0.69 (0.42–1.14)	0.59 (0.21–1.68)	5.599	0.061
Western Europe vs. North America	0.42 (0.16–1.06)	0.28 (0.13–0.62)	1.47 (0.44–4.88)	13.176	0.001
ACEI or ARB use	1.00 (0.62–1.60)	0.66 (0.49–0.89)	1.51 (0.88–2.60)	7.613	0.022
Chronic loop diuretic use	1.65 (0.91–2.96)	2.37 (1.56–3.61)	0.69 (0.34–1.42)	18.744	<0.001
Digoxin use	0.81 (0.50–1.32)	1.32 (0.98–1.76)	0.62 (0.35–1.08)	4.239	0.120
Log of creatinine (mg), per doubling	1.40 (0.94–2.08)	1.56 (1.21–2.02)	0.90 (0.56–1.42)	13.887	0.001
Respiratory rate < 20, per 5 breaths/min	0.57 (0.22–1.51)	0.51 (0.27–0.95)	1.13 (0.37–3.43)	5.406	0.067
Respiratory rate ≥20, per 5 breaths/min	1.34 (1.03–1.76)	1.17 (0.96–1.42)	1.15 (0.83–1.59)	6.778	0.034
Systolic BP < 130 mmHg, per 5 mmHg	0.95 (0.85–1.06)	0.91 (0.85–0.97)	1.04 (0.92–1.18)	8.067	0.018
Systolic BP ≥130 mmHg, per 5 mmHg	1.00 (0.91–1.11)	1.04 (0.98–1.11)	0.96 (0.86–1.08)	1.690	0.430

ACEI, angiotensin-converting enzyme inhibitor; ARB, angiotensin receptor blocker; BP, blood pressure; CI, confidence interval; OR, odds ratio.